GSK Sets Up Oncology Biz Unit in Japan; Multiple Late-Stage Assets in Pipeline

October 22, 2020
GlaxoSmithKline has established the Oncology Business Unit in Japan, with Anant Vailaya taking its helm, it has been learned. The company’s local arm, GlaxoSmithKline K.K., admitted this change on October 21, though it did not disclose the details of the...read more